Endoscopic Papillary Large Balloon Dilation Reduces Further Recurrence in Patients With Recurrent Common Bile Duct Stones: A Randomized Controlled Trial

医学 球囊扩张 内镜逆行胰胆管造影术 置信区间 随机对照试验 危险系数 胆总管 外科 胆管 内科学 气球 胰腺炎
作者
Xu Wang,Xiangping Wang,Hao Sun,Gui Ren,Biaoluo Wang,Shuhui Liang,Linhui Zhang,Xiaoyu Kang,Tao Qin,Xuegang Guo,Hui Luo,Yanglin Pan
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:117 (5): 740-747 被引量:15
标识
DOI:10.14309/ajg.0000000000001690
摘要

INTRODUCTION: Up to 60% of patients with common bile duct stone (CBDS) recurrence suffer from further recurrence after endoscopic retrograde cholangiopancreatography (ERCP). There are no effective methods to prevent recurrence in most patients. In this study, we aimed to assess the short-term and long-term efficacies of endoscopic papillary large balloon dilation (EPLBD) for the management of recurrent CBDS in a randomized controlled trial. METHODS: Consecutive patients with recurrent CBDS were eligible and randomly assigned in a 1:1 ratio to the EPLBD group or the control group. The primary outcome was the CBDS recurrence rate within 2 years after ERCP. The analysis followed the intention-to-treat principle. RESULTS: From 2014 to 2021, 180 patients with recurrent CBDS were included, with 90 in each group. All patients underwent complete CBDS clearance by 1 or several sessions of ERCP. The rate of complete clearance in 1 session was significantly higher with EPLBD treatment (95.6% vs 85.6%, P = 0.017). During the follow-up, the CBDS recurrence rate within 2 years was significantly lower in the EPLBD group than in the control group (21.1% [19/90] vs 36.7% [33/90], relative risk 0.58, 95% confidence interval 0.36–0.93, P = 0.021). At a median follow-up of approximately 56 months, CBDS recurrence was found in 34.4% of the patients (31/90) in the EPLBD group and 51.1% (46/90) in the control group (hazard ratio 0.57, 95% confidence interval 0.36–0.89, P = 0.012). Multiple recurrences (≥2) were also decreased in the EPLBD group (4.4% vs 18.9%, P = 0.020). DISCUSSION: During the long-term follow-up, nearly half of the patients with recurrent CBDS experienced stone recurrence after traditional ERCP. Our study was the first to show that EPLBD effectively reduced the recurrence of CBDS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
西瓜完成签到,获得积分10
1秒前
GQ发布了新的文献求助10
1秒前
大模型应助wucl1990采纳,获得10
1秒前
111完成签到,获得积分20
2秒前
erhao发布了新的文献求助10
2秒前
南柯一梦发布了新的文献求助10
2秒前
二掌柜发布了新的文献求助10
2秒前
李李发布了新的文献求助10
2秒前
春来完成签到,获得积分20
2秒前
3秒前
荔枝柚子发布了新的文献求助10
5秒前
5秒前
孙燕应助欣喜聪健采纳,获得50
6秒前
沉默寻凝完成签到,获得积分10
7秒前
7秒前
科研通AI5应助sundial采纳,获得10
7秒前
氪金读书发布了新的文献求助30
7秒前
8秒前
共享精神应助Rainielove0215采纳,获得10
8秒前
笑哈哈完成签到,获得积分10
10秒前
10秒前
南卡发布了新的文献求助10
10秒前
酷波er应助陈杰采纳,获得10
11秒前
12秒前
linkman发布了新的文献求助10
12秒前
顾矜应助风中的文龙采纳,获得10
13秒前
13秒前
wucl1990发布了新的文献求助10
13秒前
秦羽完成签到,获得积分10
13秒前
mklwxhlsd完成签到,获得积分10
14秒前
美好雨竹完成签到 ,获得积分10
14秒前
Kyros完成签到 ,获得积分10
14秒前
Rong发布了新的文献求助10
15秒前
雪白摇伽发布了新的文献求助10
15秒前
HowesFeng完成签到,获得积分10
16秒前
粥粥应助不会取名字采纳,获得10
16秒前
CorisKen应助科研通管家采纳,获得10
17秒前
爆米花应助科研通管家采纳,获得10
17秒前
坦率的匪应助科研通管家采纳,获得10
18秒前
无花果应助科研通管家采纳,获得10
18秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988786
求助须知:如何正确求助?哪些是违规求助? 3531116
关于积分的说明 11252493
捐赠科研通 3269766
什么是DOI,文献DOI怎么找? 1804771
邀请新用户注册赠送积分活动 881870
科研通“疑难数据库(出版商)”最低求助积分说明 809021